Manifesto on United Airways Diseases (UAD) An Interasma (Global Asthma Association) Document

Manifesto on United Airways Diseases (UAD) An Interasma (Global Asthma Association) Document

The large amount of evidence and the renewed interest in upper and lower airways involvement in infectious and inflammatory diseases has led Interasma (Global Asthma Association) to take a position on United Airways Diseases (UAD). Patients with UAD need to have a timely and adequate diagnosis, treatment, and, when recommended, referral for management in a specialised centre. Diagnostic testing including skin prick or serum specific IgE, lung function, fractional exhaled nitric oxide (FeNO), polysomnography, allergen-specific immunotherapies, biological therapies and home based continuous positive airway pressure whenever these are recommended, should be part of the management plan for UAD. This is a shortened version of the original article.

Modern Medicine – Issue 5 2021